Literature DB >> 30639226

Structural Basis for the Activation of the Deubiquitinase Calypso by the Polycomb Protein ASX.

Inessa De1, Emily C Chittock2, Helga Grötsch1, Thomas C R Miller1, Andrew A McCarthy3, Christoph W Müller4.   

Abstract

Ubiquitin C-terminal hydrolase deubiquitinase BAP1 is an essential tumor suppressor involved in cell growth control, DNA damage response, and transcriptional regulation. As part of the Polycomb repression machinery, BAP1 is activated by the deubiquitinase adaptor domain of ASXL1 mediating gene repression by cleaving ubiquitin (Ub) from histone H2A in nucleosomes. The molecular mechanism of BAP1 activation by ASXL1 remains elusive, as no structures are available for either BAP1 or ASXL1. Here, we present the crystal structure of the BAP1 ortholog from Drosophila melanogaster, named Calypso, bound to its activator, ASX, homolog of ASXL1. Based on comparative structural and functional analysis, we propose a model for Ub binding by Calypso/ASX, uncover decisive structural elements responsible for ASX-mediated Calypso activation, and characterize the interaction with ubiquitinated nucleosomes. Our results give molecular insight into Calypso function and its regulation by ASX and provide the opportunity for the rational design of mechanism-based therapeutics to treat human BAP1/ASXL1-related tumors.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRCA1-associated protein-1; Drosophila calypso/ASX complex; Polycomb group repressive deubiquitinase complex; deubiquitinating enzyme; nucleosome modifying complex

Mesh:

Substances:

Year:  2019        PMID: 30639226     DOI: 10.1016/j.str.2018.11.013

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  6 in total

1.  Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.

Authors:  Hongzhuang Peng; Joel Cassel; Daniel S McCracken; Jeremy W Prokop; Eleonora Sementino; Mitchell Cheung; Paul R Collop; Alexander Polo; Surbhi Joshi; Jacob P Mandell; Kasirajan Ayyanathan; David Hinds; S Bruce Malkowicz; J William Harbour; Anne M Bowcock; Joseph Salvino; Eileen J Kennedy; Joseph R Testa; Frank J Rauscher
Journal:  Mol Cancer Res       Date:  2021-03-17       Impact factor: 5.852

Review 2.  Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes.

Authors:  Haithem Barbour; Salima Daou; Michael Hendzel; El Bachir Affar
Journal:  Nat Commun       Date:  2020-11-23       Impact factor: 14.919

Review 3.  Emerging multifaceted roles of BAP1 complexes in biological processes.

Authors:  Aileen Patricia Szczepanski; Lu Wang
Journal:  Cell Death Discov       Date:  2021-01-22

4.  Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.

Authors:  Natsumi Tsuboyama; Ru Wang; Aileen Patricia Szczepanski; Huanhuan Chen; Zibo Zhao; Lei Shi; Lu Wang
Journal:  Oncogene       Date:  2022-02-22       Impact factor: 9.867

Review 5.  Molecular Regulation of the Polycomb Repressive-Deubiquitinase.

Authors:  Cameron J Reddington; Matthias Fellner; Abigail E Burgess; Peter D Mace
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

6.  BAP1 Downregulates NRF2 Target Genes and Exerts Anti-Tumorigenic Effects by Deubiquitinating KEAP1 in Lung Adenocarcinoma.

Authors:  Jong-Su Kang; Le Ba Nam; Ok-Kyung Yoo; Kyeong Lee; Young-Ah Suh; Dalyong Kim; Woo Kyung Kim; Chi-Yeon Lim; Haeseung Lee; Young-Sam Keum
Journal:  Antioxidants (Basel)       Date:  2022-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.